- Home
- LX vs RXST Comparison
LX vs RXST Comparison
Compare LX & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LX | RXST |
|---|---|---|
| Founded | 2013 | 1997 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 243.9M | 232.2M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LX | RXST |
|---|---|---|
| Price | $1.43 | $7.01 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 10 |
| Target Price | $3.50 | ★ $9.78 |
| AVG Volume (30 Days) | ★ 1.9M | 975.5K |
| Earning Date | 05-20-2026 | 05-06-2026 |
| Dividend Yield | ★ 18.73% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.74 | $10.06 |
| P/E Ratio | $2.08 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.41 | $4.48 |
| 52 Week High | $6.94 | $13.22 |
Technical Indicators
Market Signals| Indicator | LX | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 31.95 | 70.53 |
| Support Level | $1.41 | $5.26 |
| Resistance Level | $2.06 | $7.60 |
| Average True Range (ATR) | 0.05 | 0.38 |
| MACD | 0.02 | 0.11 |
| Stochastic Oscillator | 12.50 | 89.09 |
Price Performance
Historical ComparisonAbout LX LexinFintech Holdings Ltd.
LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.